Feed CRZBY
CR

Commerzbank AG CRZBY · OTC

$40.11 -3.60% (-$1.50)

Summary

52 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 31% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.
  • Analysts expect revenue to grow by 42% this fiscal year.
  • It bought back its own shares for 1.47B € in the last fiscal year, 3.8% of its market value.

What to watch

  • Revenue fell by 9.2% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $40.11
P/E today 12.4 10% higher
5-year average P/E 11.2
P/E today 12.4
Banks - Regional industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 12.4 EUR for 1 EUR of yearly profit. Over the last five years it was 11.2 EUR on average.

Valuation in detail

Is it growing?

Slowly

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue fell by 1.2% a year over 5 years. Over the last 3 years it fell by 9.2% a year. For the next fiscal year analysts expect revenue to grow by 42%. Earnings per share grew by 31% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 EUR of revenue goes

Net profit, industry median (Banks - Regional) 21 EUR

Out of every 100 EUR of revenue, 15 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

Moderate, safe
Yield
3.21%
Paid out of profit
40%
Raised in a row
2 years

You receive $1.29 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly negative

No analyst has published a price target.

0.0% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy